I am a Co-founder and Partner with a special focus on Rare Diseases and Gene Therapy.
My previous roles include Head of Global Market Access at ViiV Healthcare, GlaxoSmithKline and Eli Lilly. My team successfully negotiated the first ever pricing and reimbursement agreements for a gene therapy (Strimvelis).
I have experience with the founder side of fund-raising and building a company as a co-founder of a social media platform (YurOn). I have learnt how much networking with fellow entrepreneurs and getting help from mentors saves invaluable time.
I am an engineer by training, with an MSc in Maths and Physics from Ecole Polytechnique (Paris) and a Post-Graduate degree from Normal Sup / Ecole de Hautes Etudes en Sciences Sociales.